VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LGND
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LGNDLigand Pharmaceuticals Incorporated
$314.04$6.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLGNDQuarterly Financials

Ligand Pharmaceuticals Incorporated (LGND) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Ligand Pharmaceuticals Incorporated (LGND) quarterly income statement — complete revenue, gross profit & net income history

LGND Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue51.72M59.67M115.46M47.63M45.33M42.81M51.81M41.53M30.98M28.1M32.87M26.37M43.98M27.05M59.22M50.13M36.52M72.47M64.83M84.67M
Revenue Growth %14.09%39.37%122.85%14.68%46.34%52.35%57.64%57.52%-29.56%3.9%-44.5%-47.4%20.44%-62.68%-8.66%-40.8%-33.79%3.55%54.93%104.43%
Cost of Goods Sold2.08M-25.99M24.82M2.91M4.85M2.84M12.49M-15.33M11.07M1.66M3.48M1.67M3.72M21.61M14.15M12.36M4.7M11.98M11.45M30.59M
COGS % of Revenue4.01%-43.56%21.5%6.1%10.7%6.63%24.12%-36.9%35.73%5.92%10.6%6.33%8.45%79.92%23.9%24.66%12.87%16.54%17.65%36.13%
Gross Profit49.65M85.65M90.64M44.72M40.48M39.98M39.32M56.86M19.91M26.44M29.38M24.7M40.26M5.43M45.07M37.77M31.82M60.49M53.39M54.08M
Gross Margin %95.99%143.56%78.5%93.9%89.3%93.37%75.88%136.9%64.27%94.08%89.4%93.67%91.55%20.08%76.1%75.34%87.13%83.46%82.35%63.87%
Gross Profit Growth %22.63%114.27%130.54%-21.35%103.33%51.21%33.81%130.22%-50.55%386.78%-34.8%-34.6%26.54%-91.02%-15.59%-30.17%-32.3%3.84%50.41%60.12%
Operating Expenses32.28M65.61M35.71M36.28M76.7M49.61M36.17M75.96M16.92M29.8M26.3M26.68M26.06M-6.75M32.73M29.1M29.68M47.76M37.68M8.34M
OpEx % of Revenue62.41%109.97%30.93%76.17%169.19%115.88%69.82%182.89%54.63%106.03%80.03%101.19%59.25%-24.94%55.26%58.06%81.29%65.89%58.12%9.85%
Selling, General & Admin20.84M25.03M28.45M20.18M18.8M25.61M24.48M17.62M10.95M15.99M14.66M11.29M10.86M19.85M14.92M12.09M11.93M17.74M12.72M14.71M
SG&A % of Revenue40.28%41.95%24.64%42.36%41.47%59.81%47.24%42.43%35.35%56.91%44.59%42.81%24.68%73.4%25.19%24.11%32.66%24.47%19.62%17.37%
Research & Development2.15M3.51M21.02M6.57M50.09M4.42M5.67M5.35M5.97M5.49M5.53M6.85M6.66M-25.38M9.24M8.47M9.18M18.24M16.94M15.95M
R&D % of Revenue4.15%5.88%18.2%13.79%110.48%10.34%10.95%12.89%19.28%19.53%16.83%26%15.15%-93.84%15.6%16.89%25.14%25.17%26.12%18.84%
Other Operating Expenses1000K1000K-1000K1000K1000K1000K1000K1000K01000K1000K1000K1000K-1000K1000K1000K1000K1000K1000K-1000K
Operating Income17.37M20.04M54.93M8.44M-36.22M-9.64M3.14M-19.1M2.99M-3.36M3.08M-1.98M14.21M12.18M12.34M8.66M2.13M12.73M15.71M45.74M
Operating Margin %33.58%33.59%47.58%17.73%-79.89%-22.51%6.07%-45.99%9.65%-11.95%9.36%-7.52%32.3%45.02%20.84%17.28%5.84%17.57%24.22%54.02%
Operating Income Growth %147.96%307.95%1647.73%144.21%-1312.05%-186.99%2.11%-863.19%-78.97%-127.58%-75.06%-122.89%565.96%-4.38%-21.42%-81.06%-54.76%13.59%319.16%544.21%
EBITDA17.37M29.66M63.03M16.97M-27.45M-1.01M12.14M-10.25M11.75M5.56M11.69M7.51M23.77M23.31M25.85M21.75M15.78M25.68M28.32M58.03M
EBITDA Margin %33.58%49.72%54.59%35.62%-60.54%-2.36%23.43%-24.67%37.94%19.8%35.56%28.49%54.05%86.19%43.64%43.39%43.21%35.44%43.68%68.53%
EBITDA Growth %163.28%3037.03%419.29%265.57%-333.52%-118.16%3.83%-236.41%-50.56%-76.13%-54.77%-65.46%50.68%-9.24%-8.73%-62.52%-11.4%6.89%241.4%412.55%
D&A (Non-Cash Add-back)09.62M8.1M8.52M8.77M8.63M8.99M8.85M8.77M8.92M8.61M9.49M9.57M11.13M13.51M13.09M13.64M12.95M12.61M12.29M
EBIT17.37M56.78M141.14M12.38M-49.31M-38.32M-5.6M-64.12M113.59M17.23M-12.14M3.46M14.21M56.17M12.69M9.1M-8.36M-2.55M11.91M11.64M
Net Interest Income4.91M4.61M2.96M468K904K1.05M606K1.49M1.88M1.56M2.26M2.04M1.2M783K259K-140K-655K-4.28M-4.27M-4.65M
Interest Income4.91M4.61M2.96M1.62M1.77M1.93M1.35M2.76M2.02M1.69M2.26M2.32M1.44M1.02M591K298K134K188K169K233K
Interest Expense0001.15M867K883K741K1.27M141K131K1K284K240K240K332K438K789K4.47M4.44M4.88M
Other Income/Expense-41.63M36.74M86.21M2.78M-13.96M-29.56M-9.48M-46.29M110.46M20.45M-15.22M5.15M41.33M43.75M13K-1K-11.28M-19.76M-447K-12.44M
Pretax Income-24.26M56.78M141.14M11.22M-50.18M-39.2M-6.34M-65.39M113.45M17.1M-12.14M3.17M55.54M55.93M12.35M8.66M-9.14M-7.03M15.26M33.3M
Pretax Margin %-46.9%95.16%122.24%23.56%-110.69%-91.56%-12.23%-157.45%366.22%60.84%-36.95%12.03%126.28%206.8%20.86%17.28%-25.04%-9.69%23.54%39.33%
Income Tax-10.91M12M23.86M6.38M-7.73M-8.11M833K-13.48M27.31M-1.09M-1.87M881K11.92M45.27M2.71M-3.94M3.79M-1.61M1.54M2.58M
Effective Tax Rate %44.99%21.13%16.91%56.81%15.4%20.69%-13.14%20.61%24.07%-6.38%15.41%27.78%21.47%80.95%21.93%-45.47%-41.39%22.91%10.07%7.74%
Net Income-13.35M44.78M117.27M4.85M-42.45M-31.09M-7.17M-51.91M86.14M18.19M-10.27M2.29M41.95M-17.48M404K-895K-15.38M-5.42M13.72M30.73M
Net Margin %-25.8%75.06%101.57%10.18%-93.64%-72.62%-13.84%-124.99%278.07%64.72%-31.26%8.69%95.38%-64.65%0.68%-1.79%-42.13%-7.47%21.17%36.29%
Net Income Growth %68.56%244.06%1735.15%109.34%-149.28%-270.93%30.19%-2366.86%105.34%204.02%-2642.82%355.87%372.66%-222.84%-97.06%-102.91%-184.97%-194.01%304.79%39.12%
Net Income (Continuing)-13.35M44.78M117.27M4.85M-42.45M-31.09M-7.17M-51.91M86.14M18.19M-10.27M2.29M43.61M10.66M9.64M12.6M-12.93M-5.42M13.72M30.73M
Discontinued Operations000000000000-1000K0-1000K-1000K-1000K000
Minority Interest00000000000000000000
EPS (Diluted)-0.672.125.680.24-2.21-1.64-0.39-2.884.751.03-0.740.132.33-1.040.02-0.05-0.91-0.300.801.79
EPS Growth %69.68%229.27%1556.41%108.33%-146.53%-259.22%47.3%-2315.38%103.86%199.04%-3800%360%356.04%-246.67%-97.5%-102.79%-186.67%-185.71%290.48%35.61%
EPS (Basic)-0.672.275.990.25-2.21-1.64-0.39-2.884.861.04-0.740.132.46-1.040.02-0.05-0.91-0.300.821.84
Diluted Shares Outstanding19.88M21.14M20.17M19.93M19.19M18.97M18.42M18.03M18.12M17.68M17.38M17.73M17.97M16.89M17.13M16.87M16.82M16.73M17.14M17.17M
Basic Shares Outstanding19.88M19.73M19.37M19.33M19.19M18.97M18.42M18.03M17.73M17.47M17.38M17.28M17.06M16.89M16.89M16.87M16.82M16.73M16.69M16.66M
Dividend Payout Ratio--------------------